BRM BioRem Inc.

3.216USD4.600 CAD · TSXV+0.88%Mkt Cap: 57.08M USDP/E: 10.95

BioRem Inc., a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds, and hazardous air pollutants.…

Key Statistics

Company
Market Cap57.08M USD
Enterprise Value53.15M USD
Revenue (TTM)39.20M USD
Gross Profit8.92M USD
Net Income (TTM)3.37M USD
Revenue/Share2.40 USD
Last Price3.216 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees—
CountryCA
SectorIndustrials
IndustryPollution & Treatment Controls
ISINCA09068G1046
Valuation
P/E (Trailing)10.95
P/E (Forward)—
PEG—
EV/EBITDA7.15
EV/Revenue1.36
P/S1.46
P/B4.00
EPS (TTM)0.29 USD
EPS (Forward)—
52W Range
1.40592% of range3.369
52W High3.369 USD
52W Low1.405 USD
Profitability
Gross Margin30.14%
Oper. Margin18.46%
EBITDA Margin18.95%
Profit Margin11.37%
ROE32.27%
ROA14.35%
ROIC80.03%
ROCE38.49%
Growth
Revenue Growth47.80%
Earnings Growth138.70%
Cash Flow & Leverage
Operating CF5.34M USD
CapEx (TTM)257.13K USD
FCF Margin-3.19%
FCF Yield-2.19%
Net Debt-3.94M USD
Net Debt/EBITDA-0.53
Net Debt/FCF—
Balance Sheet
Debt/Equity0.19
Current Ratio2.37
Quick Ratio1.91
Book Value/Sh0.80 USD
Cash/Share0.31 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)3.495 USD
Upside (mean)+8.7%
Target Range3.495 USD – 3.495 USD
# Analysts1
Ownership
Shares Out.17.75M
Float15.39M
Insiders9.26%
Institutions0.14%
Short Interest
Short Ratio0.2d
Short % Out.0.02%
Shares Short3.10K
Short (prev mo.)257
Technical
SMA 502.634 (+22.1%)
SMA 2002.254 (+42.7%)
Beta0.93
S&P 52W Chg12.00%
Avg Vol (30d)23.26K
Avg Vol (10d)28.56K
Technical Indicators
RSI (14)68.0
MACD0.2612
MACD Signal0.2326
MACD Hist.+0.0286
BB Upper3.496 USD
BB Middle2.926 USD
BB Lower2.356 USD
BB Width38.96%
ATR (14)0.1181 USD
Vol Ratio (20d)1.82x

About BioRem (CVE: BRM)

›

BioRem (CVE: BRM) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Pollution & Treatment Controls industry, part of the Industrials sector.

The shares were at 4.600 CAD on 19 November 2026, up 123.3% over 52 weeks. Its 52-week range is 2.010 CAD to 4.820 CAD: the price is 4.6% below the high and 128.9% above the low.

At a market capitalisation of 81.66M CAD, it trades at 11.0 times trailing earnings. The median trailing P/E of its 9 largest Pollution & Treatment Controls peers is 26.1, a discount of 58% for BRM.

BioRem reports return on equity of 32.3%, an operating margin of 18.5% and revenue up 47.8% year over year.

It holds more cash than debt, a net cash position of 5.63M CAD. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. One analyst covers the stock, with an average rating of Buy; their mean price target of 5.000 CAD is 8.7% above the current price.